Bally's Corp has filed a notification of late filing for its quarterly report, which is significant as it indicates the company requires additional time to complete the review of its financial statements. The filing, submitted on November 10, 2026, pertains to the quarterly report for the period ending September 30, 2026. This delay could affect investor confidence and operational transparency for the company.
The hotel and motel industry, classified under SIC code 7011, may also feel the repercussions of this filing. Stakeholders will be closely monitoring how this situation unfolds, as it could influence perceptions of stability within the sector.
Background
Bally's Corp, traded on the NYSE under the ticker BALY, is categorized as an accelerated filer and a smaller reporting company. The company, incorporated in Delaware, operates primarily in the hotel and motel sector. It has undergone several name changes in recent years, previously known as Twin River Worldwide Holdings, Inc.
What the Filing Says
The filing states, "Bally's Corporation was unable to file its Quarterly Report on Form 10-Q for the period ended September 30, 2026, within the prescribed time period as additional time is necessary to complete the review of the Company’s financial statements." Bally's expects to file the Quarterly Report within the extension period of five calendar days permitted under Rule 12b-25 of the Securities Exchange Act of 1934.
Impact
This delay may affect various stakeholders, including investors, employees, and partners, who rely on timely and accurate financial reporting for decision-making. The inability to file on time could lead to concerns about the company’s financial health and operational efficiency.
What's Next
Bally's Corp anticipates filing the overdue Quarterly Report within the allowed extension period. The filing does not specify any further actions that will follow this notification.
Read Next
Planet 13 Holdings to Merge with Vireo Growth Inc.
Xerox amends registration statement for stock offering
GP-Act III Acquisition Corp. Announces Merger with Dronamics
Eupraxia Pharmaceuticals launches $125 million share offering
Chicago Atlantic Real Estate Finance outlines merger plans
Electra Vehicles files amended registration for merger










